Several studies have indicated an reverse association that a high, rather than a low, adiponectin level predicts adverse CV outcomes and all-cause mortality in CKD[6, 21, 22], and this association is attenuated in ESRD. The gene discussed is ADIPOQ; the disease is chronic kidney disease.